Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors

Francesco Merlino; Yang Zhou; Minying Cai; Alfonso Carotenuto; Ali M. Yousif; Diego Brancaccio; Salvatore Di Maro; Silvia Zappavigna; Antonio Limatola; Ettore Novellino; Paolo Grieco; Victor J Hruby

doi:10.1021/acs.jmedchem.8b00488

Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors

Francesco Merlino, Yang Zhou, Minying Cai, Alfonso Carotenuto, Ali M. Yousif, Diego Brancaccio, Salvatore Di Maro, Silvia Zappavigna, Antonio Limatola, Ettore Novellino, Paolo Grieco, Victor J Hruby

Chemistry and Biochemistry

Research output: Contribution to journal › Article

Abstract

We report the development of macrocyclic melanocortin derivatives of MT-II and SHU-9119, achieved by modifying the cycle dimension and incorporating constrained amino acids in ring-closing. This study culminated in the discovery of novel agonists/antagonists with an unprecedented activity profile by adding pieces to the puzzle of the melanocortin receptor selectivity. Finally, the resulting 19- and 20-membered rings represent a suitable frame for the design of further therapeutic ligands as selective modulators of the melanocortin system.

Original language	English (US)
Pages (from-to)	4263-4269
Number of pages	7
Journal	Unknown Journal
Volume	61
Issue number	9
DOIs	https://doi.org/10.1021/acs.jmedchem.8b00488
State	Published - May 10 2018

ASJC Scopus subject areas

Molecular Medicine
Drug Discovery

Access to Document

10.1021/acs.jmedchem.8b00488

Fingerprint Dive into the research topics of 'Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors'. Together they form a unique fingerprint.

Cite this

Merlino, F., Zhou, Y., Cai, M., Carotenuto, A., Yousif, A. M., Brancaccio, D., Di Maro, S., Zappavigna, S., Limatola, A., Novellino, E., Grieco, P., & Hruby, V. J. (2018). Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors. Unknown Journal, 61(9), 4263-4269. https://doi.org/10.1021/acs.jmedchem.8b00488

Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors. / Merlino, Francesco; Zhou, Yang; Cai, Minying; Carotenuto, Alfonso; Yousif, Ali M.; Brancaccio, Diego; Di Maro, Salvatore; Zappavigna, Silvia; Limatola, Antonio; Novellino, Ettore; Grieco, Paolo; Hruby, Victor J.

In: Unknown Journal, Vol. 61, No. 9, 10.05.2018, p. 4263-4269.

Research output: Contribution to journal › Article

Merlino, F, Zhou, Y, Cai, M, Carotenuto, A, Yousif, AM, Brancaccio, D, Di Maro, S, Zappavigna, S, Limatola, A, Novellino, E, Grieco, P & Hruby, VJ 2018, 'Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors', Unknown Journal, vol. 61, no. 9, pp. 4263-4269. https://doi.org/10.1021/acs.jmedchem.8b00488

Merlino, Francesco ; Zhou, Yang ; Cai, Minying ; Carotenuto, Alfonso ; Yousif, Ali M. ; Brancaccio, Diego ; Di Maro, Salvatore ; Zappavigna, Silvia ; Limatola, Antonio ; Novellino, Ettore ; Grieco, Paolo ; Hruby, Victor J. / Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors. In: Unknown Journal. 2018 ; Vol. 61, No. 9. pp. 4263-4269.

@article{bb21ca3f89d44e0fa0d80f41efbad208,

title = "Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors",

abstract = "We report the development of macrocyclic melanocortin derivatives of MT-II and SHU-9119, achieved by modifying the cycle dimension and incorporating constrained amino acids in ring-closing. This study culminated in the discovery of novel agonists/antagonists with an unprecedented activity profile by adding pieces to the puzzle of the melanocortin receptor selectivity. Finally, the resulting 19- and 20-membered rings represent a suitable frame for the design of further therapeutic ligands as selective modulators of the melanocortin system.",

author = "Francesco Merlino and Yang Zhou and Minying Cai and Alfonso Carotenuto and Yousif, {Ali M.} and Diego Brancaccio and {Di Maro}, Salvatore and Silvia Zappavigna and Antonio Limatola and Ettore Novellino and Paolo Grieco and Hruby, {Victor J}",

year = "2018",

month = may,

day = "10",

doi = "10.1021/acs.jmedchem.8b00488",

language = "English (US)",

volume = "61",

pages = "4263--4269",

journal = "Nuclear Physics A",

issn = "0375-9474",

publisher = "Elsevier",

number = "9",

}

TY - JOUR

T1 - Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors

AU - Merlino, Francesco

AU - Zhou, Yang

AU - Cai, Minying

AU - Carotenuto, Alfonso

AU - Yousif, Ali M.

AU - Brancaccio, Diego

AU - Di Maro, Salvatore

AU - Zappavigna, Silvia

AU - Limatola, Antonio

AU - Novellino, Ettore

AU - Grieco, Paolo

AU - Hruby, Victor J

PY - 2018/5/10

Y1 - 2018/5/10

N2 - We report the development of macrocyclic melanocortin derivatives of MT-II and SHU-9119, achieved by modifying the cycle dimension and incorporating constrained amino acids in ring-closing. This study culminated in the discovery of novel agonists/antagonists with an unprecedented activity profile by adding pieces to the puzzle of the melanocortin receptor selectivity. Finally, the resulting 19- and 20-membered rings represent a suitable frame for the design of further therapeutic ligands as selective modulators of the melanocortin system.

AB - We report the development of macrocyclic melanocortin derivatives of MT-II and SHU-9119, achieved by modifying the cycle dimension and incorporating constrained amino acids in ring-closing. This study culminated in the discovery of novel agonists/antagonists with an unprecedented activity profile by adding pieces to the puzzle of the melanocortin receptor selectivity. Finally, the resulting 19- and 20-membered rings represent a suitable frame for the design of further therapeutic ligands as selective modulators of the melanocortin system.

UR - http://www.scopus.com/inward/record.url?scp=85046488907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046488907&partnerID=8YFLogxK

U2 - 10.1021/acs.jmedchem.8b00488

DO - 10.1021/acs.jmedchem.8b00488

M3 - Article

C2 - 29660981

AN - SCOPUS:85046488907

VL - 61

SP - 4263

EP - 4269

JO - Nuclear Physics A

JF - Nuclear Physics A

SN - 0375-9474

IS - 9

ER -